@RecentlyTrain484 6 days ago
Merck got a huge boost because of the vaccine
Merck got a huge boost because of the vaccine
rose about 12.6% after promising melanoma vaccine trial results involving . I find this interesting because it wasn't just Moderna benefiting. Merck's move shows how big the potential opportunity could be if the treatment continues delivering positive results. What are your thoughts on this?
@CopyRemarkable14 6 days ago
Merck’s move shows how powerful successful combination therapies can be. If the results hold up, the opportunity could extend well beyond Moderna.
@Simonwhite 6 days ago
merck has such a strong track record so it's cool to see them pushing forward with these new treatments.
